SlideShare a Scribd company logo
CD
▪Dr. G.D.A. Samaranayaka
History
Definition
Nomenclature
Importance
Brief description on some CDs
Monoclonal Antibodies
▪Monoclonal antibodies (mAb or moAb)
▫antibodies made by identical immune cells - clones of a
unique parent cell.
▫monovalent affinity - bind to the same epitope.
▪Polyclonal antibodies
▫bind to multiple epitopes
▫usually made by several different plasma cell lineages.
History
▪First monoclonal antibody produced in 1975
▪With the advent of hybridoma technology to produce mAbs –
▫generate very large numbers of mAbs directed against leukocyte cell
surface molecules
▫generally using whole cells as immunogen.
▪Initially, surface antigens were named after the monoclonal
antibodies that bound to them.
▪The problem was that several mAbs produced by different
laboratories (under different names) were actually directed
against the same molecule (same antigen different epitopes).
Lab A
Lab B
Lab C
▪This resulted in the chaotic naming of molecules
▪Adaptation of a consistent nomenclature was necessary.
▪The cluster of differentiation (CD) nomenclature system was
conceived to classify antigens found on the surface of leukocytes.
Cluster of
Differentiation
▪The cluster of differentiation (CD) is a group of cell surface
molecules providing targets for immunophenotyping of cells.
▪Physiologically, CD antigens do not belong in any particular class
of molecules
Immunoglobulin (Ig) superfamily
Scavenger receptor cysteine-rich (SRCR) superfamily
TNF superfamily
Regulators of complement/CÆ activation (RCA) family
Integral membrane proteins
▪CD act as receptors or ligands to play the functions such as
cell signaling and cell adhesion etc.
▪CD system normally plays a role as a cell marker in immune
purpose to recognize the molecules in the cells’ surface.
▪Although initially used for just human leukocytes, the CD molecule
naming convention has now been expanded to cover both other species
(e.g. mouse) as well as other cell types.
▪At present, CD markers range from CD1 to CD371
▪Some CDs covering a group of closely related proteins or
carbohydrates (e.g.,CD1a,CD1b,CD1c,andCD1d).
▪The total number of assigned CDs is 401.
HDLA Workshops
▪HLDA (Human Leukocyte Differentiation Antigens) Workshops were created to
establish the nomenclature of leukocyte cell surface molecules by using mAbs from
different laboratories.
▪The current nomenclature system was adopted in 1982, during the 1st
International HLDA Workshop in Paris.
▪The HLDA Workshops have since provided a forum for the characterization and
study of leucocyte surface molecules and antibodies against them - compare the
ability of monoclonal antibodies to react with human cells and/or human cell
proteins.
▪HLDA devised the CD nomenclature, which is sanctioned by the IUIS (International
Union of Immunological Societies)/WHO Nomenclature Committee.
▪Latest work shop held in 2014 – HDLA10
Current Nomenclature
system
▪Monoclonal antibodies that have similar patterns of reactivity with
various tissues or cell types are assigned to a cluster group.
▪An antigen well recognized by a cluster or a group of of antibodies
can be assigned a cluster of differentiation number, or CD number
(e.g. CD1, CD2 etc)
▪The CD nomenclature is also used to name antigen and the
antibodies.
▫Ex:-CD4 designates both the group of mAbs recognizing the CD4
cell surface molecule, as well as the CD4 molecule itself.
▪A lowercase “w” preceding the number designation stands for “workshop”
▫e.g. CDw12
▫Indicates CD designation is tentative.
▫Denotes an insufficiently characterized Ab or molecule.
▫In some cases, corresponds to a molecule defined by only one Ab submitted to the HLDA
Workshops.
▪Most of the provisional CDw-designated Ags of the early workshops turned out
to correspond to clusters of mAbs recognizing carbohydrate epitopes, which
after proper biochemical identification received their own CD number
▫e.g., CD176 = Thomsen-Friedenreich, carbohydrate Ag
▪Uppercase letters following a CD number designate a spliced variant of the
extracellular domain of a cell surface molecule.
▫For example, CD45RA or CD45RO corresponds to splice variants of CD45.
▪A lowercase letter following the CD number - share a common chain
▫ e.g., CD1a, CD1b, CD1c, CD1d, or CD1e - β2-microglobulin.
▫Other examples are the integrin chains CD11a, CD11b, and CD11c, - share CD18 as a common chain
to form different dimers.
▪In other cases, lowercase letters have been used to name different members
of the same gene family, as is the case with CD66 (CD66a, CD66b, CD66c,
CD66d, CD66e, and CD66f).
▪The CD nomenclature is also frequently used to describe lymphocyte and
leukocyte subsets.
▪The presence or absence of a specific antigen from the surface of particular
cell or cell population is denoted with “+” or “-“ respectively. (Ex CD4+, CD34+,
CD62-)
▪If a particular CD molecule is expressed at different levels by a cell subset, the
superscript “high” or “low” can be added
▫central memory T cells are CD62L high whereas effector memory T cells are CD62L low.
▪CD4+CD45RAlowCD45ROhigh
Importance of CD
▪By monitoring the expression profiles of different CD antigens
▫Identification
▫Isolation
▫Phenotyping of cell types according to their function in various immune
processes.
▪The antibodies - useful as markers for cell populations
▫Counting
▫Separation
▫functional study of numerous subsets of cells of the immune system.
General structure of
membrane antigens
Type I
Transmembrane
proteins
▪COOH-termini in the cytoplasm and their NH2-termini outside
the cell.
▪Generally has a signal sequence at the NH2-terminus - cleaved
off after the molecule passes into the endoplasmic reticulum.
▪These proteins commonly serve as cell surface receptors
and/or ligands.
▪Many belong to the immunoglobulin superfamily. Ex – CD3
Type II
Transmembrane
proteins
▪Opposite orientation to that of type I transmembrane
proteins.
▪The NH2-terminus is located inside the cell, and the
COOH-terminus is extracellular.
▪Ex – CD70
Type III
Transmembrane
proteins
▪Cross the plasma membrane more than once. Some pass
through the bilayer as many as 12 times.
▪Because they cross the membrane multiple times - form
channels that often are used to transport ions or small
molecules through the lipid bilayer.
▪Ex - CD20 - form a calcium channel for B lymphocytes that
is required for B-cell activation.
Type IV
Transmembrane
proteins
▪Type IV proteins are also transmembrane channels but is formed by
bringing together a number of independent helical segments rather
than connected as a single polypeptide
▪None of the current CD antigens have type IV membrane
organization.
Type V
Transmembrane
proteins
▪These proteins use lipid to attach themselves to
the plasma membrane.
▪The most common attachment for extracellular
proteins - glycosyl-phosphatidylinositol (GPI)
anchor.
Type of cell CD markers
stem cells CD34+, CD31-, CD117
all leukocyte groups CD45+
Granulocyte CD45+, CD11b, CD15+, CD24+, CD114+, CD182+
Monocyte CD4, CD45+, CD14+, CD114+, CD11a, CD11b, CD91+, CD16+
T lymphocyte CD45+, CD3+
T helper cell CD45+, CD3+, CD4+
T regulatory cell CD4, CD25, FOXP3
Cytotoxic T cell CD45+, CD3+, CD8+
B lymphocyte CD45+, CD19+, CD20+, CD24+, CD38, CD22
Thrombocyte CD45+, CD61+
Natural killer cell CD16+, CD56+, CD3-, CD31, CD30, CD38
CD3
▪Belongs to immunoglobulin superfamily.
▪Found on T helper and cytotoxic cells
▪3 chains - CD3γ, CD3δ and CD3ε
▪These chains associate with a T-cell receptor
(TCR) and the ζ-chain to form TCR – complex
▪TCR complex – bind with MHC molecules ->
Generation of Activation signal
CD3
▪Useful immunohistochemical marker for T-cells in tissue sections.
▫highly specific
▫presence of CD3 at all stages of T-cell development
▪The antigen remains present in almost all T-cell lymphomas and
leukaemias
▫used to distinguish them from superficially similar B-cell and myeloid
neoplasms.
Human Tonsil stained with anti-CD3 antibody
CD4
▪Surface glycoprotein seen in – T helper cells (Th
cells) Monocytes, macrophages and dendritic
cells.
▪CD4 amplifies the signal generated by the TCR -
> assists the TCR in communicating with an
antigen-presenting cell.
▪CD4 also interacts directly with MHC class II
molecules on APCs -> antigen recognition.
CD4
▪HIV-1 uses CD4 to entry into host T cells through
viral envelope protein gp120.
▫HIV infection leads to a progressive reduction in the
number of T cells expressing CD4.
▫CD4 used as a cell marker - CD4+ cell count is used as a
prognostic indicator and measure the efficacy of the
treatment.
▪CD4 continues to be expressed in most
neoplasms derived from T helper cells.
▫CD4 immunohistochemistry - identify most forms of
peripheral T cell lymphoma and related malignant
conditions.
CD8
▪Transmembrane glycoprotein -co-receptor for the
TCR
▪Binds with MHC class I molecules.
▪Predominantly expressed on the surface of
cytotoxic T cells
▫also be found on NK cells, cortical thymocytes,
and dendritic cells.
▪Plays a main role in antigen recognition
CD16
▪Molecule of the Ig superfamily
▪It is a low affinity Fc receptor
▪FcγRIIIa (CD16a) and FcγRIIIb (CD16b)
▪Found on NK cells, neutrophils, PMNs, monocytes and macrophages.
▪Bind to the Fc portion of IgG antibodies -> activates the NK cell for
antibody dependent cell-mediated cytotoxicity (ADCC)
CD25
▪Alpha chain of the IL-2 receptor.
▪Present on activated T cells, activated B cells, some thymocytes &
myeloid precursor.
▪Expressed in most B-cell neoplasms, some acute nonlymphocytic
leukemias, neuroblastomas, and tumor infiltrating lymphocytes.
▪Used as a marker for hairy cell leukemia and diagnosis of systemic
mastocytosis.
CD34
▪AKA - Hematopoietic progenitor cell antigen
▪The CD34 (CD34+ cell) are normally expressed in hematopoietic cells of the
umbilical cord and bone marrow, mesenchymal stem cells, endothelial
progenitor cells, endothelial cells of blood vessels & mast cells.
▪Cell surface glycoprotein - cell-cell adhesion factor.
▪Mediates the attachment of stem cells to bone marrow extracellular matrix
▪CD34 - adhesion molecule - required for T cells to enter lymph nodes. It is
expressed on lymph node endothelia.
▪CD34+ cells can be isolated from blood samples using immunomagnetic or
immunofluorescent methods.
▪Antibodies can be used - to quantify and purify hematopoietic progenitor stem
cells
▪Injection of CD34+ hematopoietic stem cells - treat various diseases
▫spinal cord injury, liver cirrhosis, peripheral vascular disease, etc
CD36
▪CD36 is a broadly-expressed integral membrane glycoprotein with
multiple physiological functions.
▪Found on platelets, erythrocytes, monocytes, differentiated adipocytes,
skeletal muscle, epithelial cells, spleen cells
▪AKA - Platelet glycoprotein 4, fatty acid translocase (FAT), scavenger
receptor class B member 3 (SCARB3), and glycoproteins 88 (GP88)
CD45
▪Protein tyrosine phosphatase- receptor type C (PTPRC)
▪Regulate a variety of cellular processes - cell growth, differentiation, mitotic cycle, and
oncogenic transformation.
▪Multiple isoforms - CD45RA, CD45RB, CD45RC, CD45RAB, CD45RAC, CD45RBC,
CD45RO, CD45R –
▫Present on all differentiated hematopoietic cells, except erythrocytes and plasma cells
▪This gene is specifically expressed in hematopoietic cells.
▪CD45 is a pan-leukocyte protein - routinely used in scientific research to allow
identification of cells.
▪Binds many ligands - collagen, thrombospondin, erythrocytes parasitized with
Plasmodium falciparum
▪Mutations in the human CD36 gene – lack of platelet glycoprotein IV (GPIV) -
> Nak antibody -> Platelet refractoriness
▪CD36 has also been implicated in hemostasis, thrombosis, malaria,
inflammation, lipid metabolism and atherogenesis.
CD109
▪Glycosylphosphatidylinositol (GPI)–linked glycoprotein.
▪Macroglobulin/complement family.
▪Found on - subset of hematopoietic stem cells, activated platelets and T
cells.
▪Human platelet antigen HPA 15-a (Govb) and 15-b (Gova) associated
with CD109.
▪HPA 15 antigens – liable in storage – detection using serological
methods is difficult
CD114
▪Granulocyte colony-stimulating factor receptor (G-CSF-R)
▪Cytokine receptors - haematopoietin receptor family.
▪G-CSF-R present on precursor cells in the bone marrow
▪Stimulation by GCSF - initiates cell proliferation and differentiation into
mature neutrophilic granulocytes and macrophages.
CD117
▪Stem cell growth factor receptor (SCFR) - AKA proto-oncogene c-Kit
▫ encoded by KIT gene.
▪High levels of CD117 - HSCs, multipotent progenitors (MPP), and common myeloid
progenitors (CMP).
▪Binds with stem cell factor (c-kit ligand) – stem-cell survival, proliferation, differentiation
and mobilization.
▪PBSC collection - G-CSF indirectly activates CD117.
▪Direct CD117 agonists are currently being developed as mobilization agents.
▪Activating mutations gene are associated with gastrointestinal stromal tumors,
testicular seminoma, melanoma, acute myeloid leukemia.
References
1. Cluster of Differentiation (CD); Ma Hongbao, Margaret Young, Yang Yan; New York
Science Journal 2015;8(7)
2. CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a
Driving Force in Immunology; Pablo Engel, Laurence Boumsell, Valter Gattei, Vaclav
Horejsi, Robert Balderas, Bo-Quan Jin, Fabio Malavasi, Frank Mortari, Menno C. van
Zelm,Reinhard Schwartz-Albiez, Heddy Zola, Armand Bensussan, Hannes Stockinger, and
Georgina Clark; Journal of Immunology 2015; 195:4555-4563;
3. Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5
family of thioester-containing proteins; Martin Lin, D. Robert Sutherland, Wendy Horsfall,
Nicholas Totty, Erik Yeo, Rakash Nayar, Xiang-Fu Wu and Andre C. Schuh; Blood 2002
99:1683-1691
4. Guide to human CD antigens; Abcam
5. William’s Haematology – 8th edition
6. Rossis’s Transfusion Medicine – 5th edition
7. Wikipedia
Thank You

More Related Content

What's hot

Cancer Immunology
Cancer Immunology Cancer Immunology
Cancer Immunology
Asnad Khan
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
Ashwini Gowda
 
Dendritic cells
Dendritic cellsDendritic cells
Dendritic cells
Manisha Thakur
 
IMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORSIMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORS
Saajida Sultaana
 
Cell block in cytology
Cell block in cytologyCell block in cytology
Cell block in cytology
Anam Khurshid
 
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
Kamaraj College of Engineering & Technology, Virudhunagar
 
Immunosurveillance
ImmunosurveillanceImmunosurveillance
Immunosurveillance
dr. paripurna baruah
 
HLA system and major histocompatibility complex
HLA system and major histocompatibility complexHLA system and major histocompatibility complex
HLA system and major histocompatibility complex
Soujanya Pharm.D
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
Thangam Venkatesan
 
Stem cell enumeration
Stem cell enumeration Stem cell enumeration
Stem cell enumeration
Varun Singh
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Hla typing and its role in tissue transplantation
Hla typing and its role in tissue transplantationHla typing and its role in tissue transplantation
Hla typing and its role in tissue transplantation
regional institute of medical sciences
 
Platelet Function Tests
Platelet Function TestsPlatelet Function Tests
Platelet Function Tests
Ahmed Makboul
 
CdC CROSSMATCH(CDCXM)
CdC CROSSMATCH(CDCXM)CdC CROSSMATCH(CDCXM)
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Dr Siddartha
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
Dr. Liza Bulsara
 
Somatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationSomatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationMiriya Johnson
 
Cd4 and cd8 cells by RK
Cd4 and cd8 cells by RKCd4 and cd8 cells by RK
Cd4 and cd8 cells by RK
Ranjeettaram
 
Apheresis
ApheresisApheresis
Apheresis
Ekta Jajodia
 

What's hot (20)

Cancer Immunology
Cancer Immunology Cancer Immunology
Cancer Immunology
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
 
Dendritic cells
Dendritic cellsDendritic cells
Dendritic cells
 
IMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORSIMMUNE RESPONSE TO TUMORS
IMMUNE RESPONSE TO TUMORS
 
Cell block in cytology
Cell block in cytologyCell block in cytology
Cell block in cytology
 
T cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiationT cell development, maturation, activation and differentiation
T cell development, maturation, activation and differentiation
 
Immunosurveillance
ImmunosurveillanceImmunosurveillance
Immunosurveillance
 
HLA system and major histocompatibility complex
HLA system and major histocompatibility complexHLA system and major histocompatibility complex
HLA system and major histocompatibility complex
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
Stem cell enumeration
Stem cell enumeration Stem cell enumeration
Stem cell enumeration
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Hla typing and its role in tissue transplantation
Hla typing and its role in tissue transplantationHla typing and its role in tissue transplantation
Hla typing and its role in tissue transplantation
 
Platelet Function Tests
Platelet Function TestsPlatelet Function Tests
Platelet Function Tests
 
Lymphocytes
LymphocytesLymphocytes
Lymphocytes
 
CdC CROSSMATCH(CDCXM)
CdC CROSSMATCH(CDCXM)CdC CROSSMATCH(CDCXM)
CdC CROSSMATCH(CDCXM)
 
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
 
Somatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturationSomatic hypermutation and affinity maturation
Somatic hypermutation and affinity maturation
 
Cd4 and cd8 cells by RK
Cd4 and cd8 cells by RKCd4 and cd8 cells by RK
Cd4 and cd8 cells by RK
 
Apheresis
ApheresisApheresis
Apheresis
 

Similar to Cluster of differentiation

Leukopoiesis and Leukopoietic Function.ppt
Leukopoiesis and Leukopoietic Function.pptLeukopoiesis and Leukopoietic Function.ppt
Leukopoiesis and Leukopoietic Function.ppt
Dr.Abdulrazzak Alagbari
 
Dendritic Cell in Oncology
Dendritic Cell in OncologyDendritic Cell in Oncology
Dendritic Cell in Oncology
Dr.Bhavin Vadodariya
 
HLA typing.ppt
HLA typing.pptHLA typing.ppt
HLA typing.ppt
Tilak Saha
 
dendritic cells/cosmetic dentistry courses
dendritic cells/cosmetic dentistry coursesdendritic cells/cosmetic dentistry courses
dendritic cells/cosmetic dentistry courses
Indian dental academy
 
Prof.dr.moh'd sorour bch
Prof.dr.moh'd sorour bchProf.dr.moh'd sorour bch
Prof.dr.moh'd sorour bchmohammed4450
 
T cell and NK-cell neoplasms
T cell and NK-cell neoplasmsT cell and NK-cell neoplasms
T cell and NK-cell neoplasms
Abdullah Hashish
 
Flow cytometry` dr nidhi
Flow cytometry` dr nidhiFlow cytometry` dr nidhi
Flow cytometry` dr nidhi
Dr Nidhi Rai Gupta
 
TISSUE TYPING .pptx
TISSUE TYPING                       .pptxTISSUE TYPING                       .pptx
TISSUE TYPING .pptx
KARTHIK REDDY C A
 
sehras.pptx
sehras.pptxsehras.pptx
sehras.pptx
ShoaibKhatik3
 
Lymphocytes
LymphocytesLymphocytes
Lymphocytes
Drshilpa Soni
 
Dr. nahla farahat immunophenotyping of multiple myeloma
Dr. nahla farahat   immunophenotyping of multiple myeloma Dr. nahla farahat   immunophenotyping of multiple myeloma
Dr. nahla farahat immunophenotyping of multiple myeloma
Hitham Esam
 
Hla typing 2
Hla typing 2Hla typing 2
Hla typing 2
deepak deshkar
 
Maturation of B &T Lymphocyte
Maturation of B &T LymphocyteMaturation of B &T Lymphocyte
Maturation of B &T Lymphocyte
UTTARAN MODHUKALYA
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
danielmwandu
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
AngelCharles7
 
Molecular pathology of lymphoma by dr ramesh
Molecular pathology of  lymphoma by dr ramesh Molecular pathology of  lymphoma by dr ramesh
Molecular pathology of lymphoma by dr ramesh Ramesh Purohit
 
Dendritic cells biology of the skin
Dendritic cells biology of the skinDendritic cells biology of the skin
Dendritic cells biology of the skin
Indian dental academy
 

Similar to Cluster of differentiation (20)

Leukopoiesis and Leukopoietic Function.ppt
Leukopoiesis and Leukopoietic Function.pptLeukopoiesis and Leukopoietic Function.ppt
Leukopoiesis and Leukopoietic Function.ppt
 
Dendritic Cell in Oncology
Dendritic Cell in OncologyDendritic Cell in Oncology
Dendritic Cell in Oncology
 
HLA typing.ppt
HLA typing.pptHLA typing.ppt
HLA typing.ppt
 
dendritic cells/cosmetic dentistry courses
dendritic cells/cosmetic dentistry coursesdendritic cells/cosmetic dentistry courses
dendritic cells/cosmetic dentistry courses
 
Prof.dr.moh'd sorour bch
Prof.dr.moh'd sorour bchProf.dr.moh'd sorour bch
Prof.dr.moh'd sorour bch
 
T cell and NK-cell neoplasms
T cell and NK-cell neoplasmsT cell and NK-cell neoplasms
T cell and NK-cell neoplasms
 
Flow cytometry` dr nidhi
Flow cytometry` dr nidhiFlow cytometry` dr nidhi
Flow cytometry` dr nidhi
 
G.2014-immuno~ (9.apc-jyh)
 G.2014-immuno~ (9.apc-jyh) G.2014-immuno~ (9.apc-jyh)
G.2014-immuno~ (9.apc-jyh)
 
TISSUE TYPING .pptx
TISSUE TYPING                       .pptxTISSUE TYPING                       .pptx
TISSUE TYPING .pptx
 
sehras.pptx
sehras.pptxsehras.pptx
sehras.pptx
 
Lymphocytes
LymphocytesLymphocytes
Lymphocytes
 
Dr. nahla farahat immunophenotyping of multiple myeloma
Dr. nahla farahat   immunophenotyping of multiple myeloma Dr. nahla farahat   immunophenotyping of multiple myeloma
Dr. nahla farahat immunophenotyping of multiple myeloma
 
PlOSone paper
PlOSone paperPlOSone paper
PlOSone paper
 
Hla typing 2
Hla typing 2Hla typing 2
Hla typing 2
 
Maturation of B &T Lymphocyte
Maturation of B &T LymphocyteMaturation of B &T Lymphocyte
Maturation of B &T Lymphocyte
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
 
L1.0 Immune System component .pptx
L1.0 Immune System component .pptxL1.0 Immune System component .pptx
L1.0 Immune System component .pptx
 
4 cd1a reciclagem
4 cd1a reciclagem4 cd1a reciclagem
4 cd1a reciclagem
 
Molecular pathology of lymphoma by dr ramesh
Molecular pathology of  lymphoma by dr ramesh Molecular pathology of  lymphoma by dr ramesh
Molecular pathology of lymphoma by dr ramesh
 
Dendritic cells biology of the skin
Dendritic cells biology of the skinDendritic cells biology of the skin
Dendritic cells biology of the skin
 

More from Arjuna Samaranayaka

Basic life support
Basic life supportBasic life support
Basic life support
Arjuna Samaranayaka
 
Artificial Blood Substitutes
Artificial Blood SubstitutesArtificial Blood Substitutes
Artificial Blood Substitutes
Arjuna Samaranayaka
 
Red cell antigens and functions
Red cell antigens and functionsRed cell antigens and functions
Red cell antigens and functions
Arjuna Samaranayaka
 
Quality assurance in immunohaematology laboratory
Quality assurance in immunohaematology laboratory Quality assurance in immunohaematology laboratory
Quality assurance in immunohaematology laboratory
Arjuna Samaranayaka
 
Perioperative management of Jehovah's Witnesses
Perioperative management of Jehovah's WitnessesPerioperative management of Jehovah's Witnesses
Perioperative management of Jehovah's Witnesses
Arjuna Samaranayaka
 
Neutrophil Antigens
Neutrophil Antigens Neutrophil Antigens
Neutrophil Antigens
Arjuna Samaranayaka
 
Foetal and neonatal alloimmune thrombocytopenia
Foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia
Foetal and neonatal alloimmune thrombocytopenia
Arjuna Samaranayaka
 
Immunocamouflaged red cells
Immunocamouflaged red cellsImmunocamouflaged red cells
Immunocamouflaged red cells
Arjuna Samaranayaka
 
External Quality Assurance of Serological Testing
External Quality Assurance of Serological TestingExternal Quality Assurance of Serological Testing
External Quality Assurance of Serological Testing
Arjuna Samaranayaka
 
Electronic crossmatch
Electronic crossmatchElectronic crossmatch
Electronic crossmatch
Arjuna Samaranayaka
 
Biosafety and Waste Management in Blood Transfusion Service
Biosafety and Waste Management in Blood Transfusion ServiceBiosafety and Waste Management in Blood Transfusion Service
Biosafety and Waste Management in Blood Transfusion Service
Arjuna Samaranayaka
 
Knowledge and Awareness of Blood Donors
Knowledge and Awareness of Blood DonorsKnowledge and Awareness of Blood Donors
Knowledge and Awareness of Blood Donors
Arjuna Samaranayaka
 
Rh D Variants
Rh D VariantsRh D Variants
Rh D Variants
Arjuna Samaranayaka
 
Scope.pptx
Scope.pptxScope.pptx
Health communication in blood transfusion service
Health communication in blood transfusion serviceHealth communication in blood transfusion service
Health communication in blood transfusion service
Arjuna Samaranayaka
 
Basics of Planing.pptx
Basics of Planing.pptxBasics of Planing.pptx
Basics of Planing.pptx
Arjuna Samaranayaka
 
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
Arjuna Samaranayaka
 
Cell based model of coagulation
Cell based model of coagulationCell based model of coagulation
Cell based model of coagulation
Arjuna Samaranayaka
 
Flowcytometry in Transfusion Medicine
Flowcytometry in Transfusion MedicineFlowcytometry in Transfusion Medicine
Flowcytometry in Transfusion Medicine
Arjuna Samaranayaka
 
Molecular testing in Fetal and Neonatal Alloimmune Thrombocytopenia
Molecular testing  in Fetal and Neonatal Alloimmune Thrombocytopenia Molecular testing  in Fetal and Neonatal Alloimmune Thrombocytopenia
Molecular testing in Fetal and Neonatal Alloimmune Thrombocytopenia
Arjuna Samaranayaka
 

More from Arjuna Samaranayaka (20)

Basic life support
Basic life supportBasic life support
Basic life support
 
Artificial Blood Substitutes
Artificial Blood SubstitutesArtificial Blood Substitutes
Artificial Blood Substitutes
 
Red cell antigens and functions
Red cell antigens and functionsRed cell antigens and functions
Red cell antigens and functions
 
Quality assurance in immunohaematology laboratory
Quality assurance in immunohaematology laboratory Quality assurance in immunohaematology laboratory
Quality assurance in immunohaematology laboratory
 
Perioperative management of Jehovah's Witnesses
Perioperative management of Jehovah's WitnessesPerioperative management of Jehovah's Witnesses
Perioperative management of Jehovah's Witnesses
 
Neutrophil Antigens
Neutrophil Antigens Neutrophil Antigens
Neutrophil Antigens
 
Foetal and neonatal alloimmune thrombocytopenia
Foetal and neonatal alloimmune thrombocytopeniaFoetal and neonatal alloimmune thrombocytopenia
Foetal and neonatal alloimmune thrombocytopenia
 
Immunocamouflaged red cells
Immunocamouflaged red cellsImmunocamouflaged red cells
Immunocamouflaged red cells
 
External Quality Assurance of Serological Testing
External Quality Assurance of Serological TestingExternal Quality Assurance of Serological Testing
External Quality Assurance of Serological Testing
 
Electronic crossmatch
Electronic crossmatchElectronic crossmatch
Electronic crossmatch
 
Biosafety and Waste Management in Blood Transfusion Service
Biosafety and Waste Management in Blood Transfusion ServiceBiosafety and Waste Management in Blood Transfusion Service
Biosafety and Waste Management in Blood Transfusion Service
 
Knowledge and Awareness of Blood Donors
Knowledge and Awareness of Blood DonorsKnowledge and Awareness of Blood Donors
Knowledge and Awareness of Blood Donors
 
Rh D Variants
Rh D VariantsRh D Variants
Rh D Variants
 
Scope.pptx
Scope.pptxScope.pptx
Scope.pptx
 
Health communication in blood transfusion service
Health communication in blood transfusion serviceHealth communication in blood transfusion service
Health communication in blood transfusion service
 
Basics of Planing.pptx
Basics of Planing.pptxBasics of Planing.pptx
Basics of Planing.pptx
 
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
ලේ දන්දීම පිළිබඳ රුධිර දායකයින් දැනුවත් කිරීම (Blood donor awareness programme)
 
Cell based model of coagulation
Cell based model of coagulationCell based model of coagulation
Cell based model of coagulation
 
Flowcytometry in Transfusion Medicine
Flowcytometry in Transfusion MedicineFlowcytometry in Transfusion Medicine
Flowcytometry in Transfusion Medicine
 
Molecular testing in Fetal and Neonatal Alloimmune Thrombocytopenia
Molecular testing  in Fetal and Neonatal Alloimmune Thrombocytopenia Molecular testing  in Fetal and Neonatal Alloimmune Thrombocytopenia
Molecular testing in Fetal and Neonatal Alloimmune Thrombocytopenia
 

Recently uploaded

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 

Recently uploaded (20)

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 

Cluster of differentiation

  • 2.
  • 3.
  • 5. Monoclonal Antibodies ▪Monoclonal antibodies (mAb or moAb) ▫antibodies made by identical immune cells - clones of a unique parent cell. ▫monovalent affinity - bind to the same epitope. ▪Polyclonal antibodies ▫bind to multiple epitopes ▫usually made by several different plasma cell lineages.
  • 6.
  • 7. History ▪First monoclonal antibody produced in 1975 ▪With the advent of hybridoma technology to produce mAbs – ▫generate very large numbers of mAbs directed against leukocyte cell surface molecules ▫generally using whole cells as immunogen. ▪Initially, surface antigens were named after the monoclonal antibodies that bound to them.
  • 8. ▪The problem was that several mAbs produced by different laboratories (under different names) were actually directed against the same molecule (same antigen different epitopes). Lab A Lab B Lab C
  • 9. ▪This resulted in the chaotic naming of molecules ▪Adaptation of a consistent nomenclature was necessary. ▪The cluster of differentiation (CD) nomenclature system was conceived to classify antigens found on the surface of leukocytes.
  • 10. Cluster of Differentiation ▪The cluster of differentiation (CD) is a group of cell surface molecules providing targets for immunophenotyping of cells.
  • 11. ▪Physiologically, CD antigens do not belong in any particular class of molecules Immunoglobulin (Ig) superfamily Scavenger receptor cysteine-rich (SRCR) superfamily TNF superfamily Regulators of complement/CÆ activation (RCA) family Integral membrane proteins ▪CD act as receptors or ligands to play the functions such as cell signaling and cell adhesion etc. ▪CD system normally plays a role as a cell marker in immune purpose to recognize the molecules in the cells’ surface.
  • 12. ▪Although initially used for just human leukocytes, the CD molecule naming convention has now been expanded to cover both other species (e.g. mouse) as well as other cell types. ▪At present, CD markers range from CD1 to CD371 ▪Some CDs covering a group of closely related proteins or carbohydrates (e.g.,CD1a,CD1b,CD1c,andCD1d). ▪The total number of assigned CDs is 401.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17. HDLA Workshops ▪HLDA (Human Leukocyte Differentiation Antigens) Workshops were created to establish the nomenclature of leukocyte cell surface molecules by using mAbs from different laboratories. ▪The current nomenclature system was adopted in 1982, during the 1st International HLDA Workshop in Paris. ▪The HLDA Workshops have since provided a forum for the characterization and study of leucocyte surface molecules and antibodies against them - compare the ability of monoclonal antibodies to react with human cells and/or human cell proteins. ▪HLDA devised the CD nomenclature, which is sanctioned by the IUIS (International Union of Immunological Societies)/WHO Nomenclature Committee. ▪Latest work shop held in 2014 – HDLA10
  • 18. Current Nomenclature system ▪Monoclonal antibodies that have similar patterns of reactivity with various tissues or cell types are assigned to a cluster group. ▪An antigen well recognized by a cluster or a group of of antibodies can be assigned a cluster of differentiation number, or CD number (e.g. CD1, CD2 etc) ▪The CD nomenclature is also used to name antigen and the antibodies. ▫Ex:-CD4 designates both the group of mAbs recognizing the CD4 cell surface molecule, as well as the CD4 molecule itself.
  • 19. ▪A lowercase “w” preceding the number designation stands for “workshop” ▫e.g. CDw12 ▫Indicates CD designation is tentative. ▫Denotes an insufficiently characterized Ab or molecule. ▫In some cases, corresponds to a molecule defined by only one Ab submitted to the HLDA Workshops. ▪Most of the provisional CDw-designated Ags of the early workshops turned out to correspond to clusters of mAbs recognizing carbohydrate epitopes, which after proper biochemical identification received their own CD number ▫e.g., CD176 = Thomsen-Friedenreich, carbohydrate Ag
  • 20. ▪Uppercase letters following a CD number designate a spliced variant of the extracellular domain of a cell surface molecule. ▫For example, CD45RA or CD45RO corresponds to splice variants of CD45. ▪A lowercase letter following the CD number - share a common chain ▫ e.g., CD1a, CD1b, CD1c, CD1d, or CD1e - β2-microglobulin. ▫Other examples are the integrin chains CD11a, CD11b, and CD11c, - share CD18 as a common chain to form different dimers. ▪In other cases, lowercase letters have been used to name different members of the same gene family, as is the case with CD66 (CD66a, CD66b, CD66c, CD66d, CD66e, and CD66f).
  • 21. ▪The CD nomenclature is also frequently used to describe lymphocyte and leukocyte subsets. ▪The presence or absence of a specific antigen from the surface of particular cell or cell population is denoted with “+” or “-“ respectively. (Ex CD4+, CD34+, CD62-) ▪If a particular CD molecule is expressed at different levels by a cell subset, the superscript “high” or “low” can be added ▫central memory T cells are CD62L high whereas effector memory T cells are CD62L low. ▪CD4+CD45RAlowCD45ROhigh
  • 22. Importance of CD ▪By monitoring the expression profiles of different CD antigens ▫Identification ▫Isolation ▫Phenotyping of cell types according to their function in various immune processes. ▪The antibodies - useful as markers for cell populations ▫Counting ▫Separation ▫functional study of numerous subsets of cells of the immune system.
  • 24. Type I Transmembrane proteins ▪COOH-termini in the cytoplasm and their NH2-termini outside the cell. ▪Generally has a signal sequence at the NH2-terminus - cleaved off after the molecule passes into the endoplasmic reticulum. ▪These proteins commonly serve as cell surface receptors and/or ligands. ▪Many belong to the immunoglobulin superfamily. Ex – CD3
  • 25. Type II Transmembrane proteins ▪Opposite orientation to that of type I transmembrane proteins. ▪The NH2-terminus is located inside the cell, and the COOH-terminus is extracellular. ▪Ex – CD70
  • 26. Type III Transmembrane proteins ▪Cross the plasma membrane more than once. Some pass through the bilayer as many as 12 times. ▪Because they cross the membrane multiple times - form channels that often are used to transport ions or small molecules through the lipid bilayer. ▪Ex - CD20 - form a calcium channel for B lymphocytes that is required for B-cell activation.
  • 27. Type IV Transmembrane proteins ▪Type IV proteins are also transmembrane channels but is formed by bringing together a number of independent helical segments rather than connected as a single polypeptide ▪None of the current CD antigens have type IV membrane organization.
  • 28. Type V Transmembrane proteins ▪These proteins use lipid to attach themselves to the plasma membrane. ▪The most common attachment for extracellular proteins - glycosyl-phosphatidylinositol (GPI) anchor.
  • 29. Type of cell CD markers stem cells CD34+, CD31-, CD117 all leukocyte groups CD45+ Granulocyte CD45+, CD11b, CD15+, CD24+, CD114+, CD182+ Monocyte CD4, CD45+, CD14+, CD114+, CD11a, CD11b, CD91+, CD16+ T lymphocyte CD45+, CD3+ T helper cell CD45+, CD3+, CD4+ T regulatory cell CD4, CD25, FOXP3 Cytotoxic T cell CD45+, CD3+, CD8+ B lymphocyte CD45+, CD19+, CD20+, CD24+, CD38, CD22 Thrombocyte CD45+, CD61+ Natural killer cell CD16+, CD56+, CD3-, CD31, CD30, CD38
  • 30. CD3 ▪Belongs to immunoglobulin superfamily. ▪Found on T helper and cytotoxic cells ▪3 chains - CD3γ, CD3δ and CD3ε ▪These chains associate with a T-cell receptor (TCR) and the ζ-chain to form TCR – complex ▪TCR complex – bind with MHC molecules -> Generation of Activation signal
  • 31. CD3 ▪Useful immunohistochemical marker for T-cells in tissue sections. ▫highly specific ▫presence of CD3 at all stages of T-cell development ▪The antigen remains present in almost all T-cell lymphomas and leukaemias ▫used to distinguish them from superficially similar B-cell and myeloid neoplasms. Human Tonsil stained with anti-CD3 antibody
  • 32. CD4 ▪Surface glycoprotein seen in – T helper cells (Th cells) Monocytes, macrophages and dendritic cells. ▪CD4 amplifies the signal generated by the TCR - > assists the TCR in communicating with an antigen-presenting cell. ▪CD4 also interacts directly with MHC class II molecules on APCs -> antigen recognition.
  • 33. CD4 ▪HIV-1 uses CD4 to entry into host T cells through viral envelope protein gp120. ▫HIV infection leads to a progressive reduction in the number of T cells expressing CD4. ▫CD4 used as a cell marker - CD4+ cell count is used as a prognostic indicator and measure the efficacy of the treatment. ▪CD4 continues to be expressed in most neoplasms derived from T helper cells. ▫CD4 immunohistochemistry - identify most forms of peripheral T cell lymphoma and related malignant conditions.
  • 34. CD8 ▪Transmembrane glycoprotein -co-receptor for the TCR ▪Binds with MHC class I molecules. ▪Predominantly expressed on the surface of cytotoxic T cells ▫also be found on NK cells, cortical thymocytes, and dendritic cells. ▪Plays a main role in antigen recognition
  • 35. CD16 ▪Molecule of the Ig superfamily ▪It is a low affinity Fc receptor ▪FcγRIIIa (CD16a) and FcγRIIIb (CD16b) ▪Found on NK cells, neutrophils, PMNs, monocytes and macrophages. ▪Bind to the Fc portion of IgG antibodies -> activates the NK cell for antibody dependent cell-mediated cytotoxicity (ADCC)
  • 36. CD25 ▪Alpha chain of the IL-2 receptor. ▪Present on activated T cells, activated B cells, some thymocytes & myeloid precursor. ▪Expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, neuroblastomas, and tumor infiltrating lymphocytes. ▪Used as a marker for hairy cell leukemia and diagnosis of systemic mastocytosis.
  • 37. CD34 ▪AKA - Hematopoietic progenitor cell antigen ▪The CD34 (CD34+ cell) are normally expressed in hematopoietic cells of the umbilical cord and bone marrow, mesenchymal stem cells, endothelial progenitor cells, endothelial cells of blood vessels & mast cells. ▪Cell surface glycoprotein - cell-cell adhesion factor. ▪Mediates the attachment of stem cells to bone marrow extracellular matrix ▪CD34 - adhesion molecule - required for T cells to enter lymph nodes. It is expressed on lymph node endothelia.
  • 38. ▪CD34+ cells can be isolated from blood samples using immunomagnetic or immunofluorescent methods. ▪Antibodies can be used - to quantify and purify hematopoietic progenitor stem cells ▪Injection of CD34+ hematopoietic stem cells - treat various diseases ▫spinal cord injury, liver cirrhosis, peripheral vascular disease, etc
  • 39. CD36 ▪CD36 is a broadly-expressed integral membrane glycoprotein with multiple physiological functions. ▪Found on platelets, erythrocytes, monocytes, differentiated adipocytes, skeletal muscle, epithelial cells, spleen cells ▪AKA - Platelet glycoprotein 4, fatty acid translocase (FAT), scavenger receptor class B member 3 (SCARB3), and glycoproteins 88 (GP88)
  • 40. CD45 ▪Protein tyrosine phosphatase- receptor type C (PTPRC) ▪Regulate a variety of cellular processes - cell growth, differentiation, mitotic cycle, and oncogenic transformation. ▪Multiple isoforms - CD45RA, CD45RB, CD45RC, CD45RAB, CD45RAC, CD45RBC, CD45RO, CD45R – ▫Present on all differentiated hematopoietic cells, except erythrocytes and plasma cells ▪This gene is specifically expressed in hematopoietic cells. ▪CD45 is a pan-leukocyte protein - routinely used in scientific research to allow identification of cells.
  • 41. ▪Binds many ligands - collagen, thrombospondin, erythrocytes parasitized with Plasmodium falciparum ▪Mutations in the human CD36 gene – lack of platelet glycoprotein IV (GPIV) - > Nak antibody -> Platelet refractoriness ▪CD36 has also been implicated in hemostasis, thrombosis, malaria, inflammation, lipid metabolism and atherogenesis.
  • 42. CD109 ▪Glycosylphosphatidylinositol (GPI)–linked glycoprotein. ▪Macroglobulin/complement family. ▪Found on - subset of hematopoietic stem cells, activated platelets and T cells. ▪Human platelet antigen HPA 15-a (Govb) and 15-b (Gova) associated with CD109. ▪HPA 15 antigens – liable in storage – detection using serological methods is difficult
  • 43. CD114 ▪Granulocyte colony-stimulating factor receptor (G-CSF-R) ▪Cytokine receptors - haematopoietin receptor family. ▪G-CSF-R present on precursor cells in the bone marrow ▪Stimulation by GCSF - initiates cell proliferation and differentiation into mature neutrophilic granulocytes and macrophages.
  • 44. CD117 ▪Stem cell growth factor receptor (SCFR) - AKA proto-oncogene c-Kit ▫ encoded by KIT gene. ▪High levels of CD117 - HSCs, multipotent progenitors (MPP), and common myeloid progenitors (CMP). ▪Binds with stem cell factor (c-kit ligand) – stem-cell survival, proliferation, differentiation and mobilization. ▪PBSC collection - G-CSF indirectly activates CD117. ▪Direct CD117 agonists are currently being developed as mobilization agents. ▪Activating mutations gene are associated with gastrointestinal stromal tumors, testicular seminoma, melanoma, acute myeloid leukemia.
  • 45.
  • 46. References 1. Cluster of Differentiation (CD); Ma Hongbao, Margaret Young, Yang Yan; New York Science Journal 2015;8(7) 2. CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology; Pablo Engel, Laurence Boumsell, Valter Gattei, Vaclav Horejsi, Robert Balderas, Bo-Quan Jin, Fabio Malavasi, Frank Mortari, Menno C. van Zelm,Reinhard Schwartz-Albiez, Heddy Zola, Armand Bensussan, Hannes Stockinger, and Georgina Clark; Journal of Immunology 2015; 195:4555-4563; 3. Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins; Martin Lin, D. Robert Sutherland, Wendy Horsfall, Nicholas Totty, Erik Yeo, Rakash Nayar, Xiang-Fu Wu and Andre C. Schuh; Blood 2002 99:1683-1691 4. Guide to human CD antigens; Abcam 5. William’s Haematology – 8th edition 6. Rossis’s Transfusion Medicine – 5th edition 7. Wikipedia

Editor's Notes

  1. spliced variant - that results in a single gene coding for multiple proteins
  2. CD117 is a proto-oncogene, meaning that overexpression or mutations of this protein can lead to cancer.